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A recombinant andem of ‘chimeric’ mouselhuman immunoglobulin (Ig) genes was constructed and inserted into plasmid pGEM1 under the control 
of the T7 bacteriophage RNA polymerase promoter. Lymphoid (Sp2/0) and non-lymphoid (CHO) cell lines used for transfection contained in their 
genomes a semisynthetic gene of T7 RNA polymerase and steadily expressed this enzyme. It was shown for the first time that a stable polycystronic 
transcription of the Ig gene tandem occurs under the control of a single T7 phage promoter, both in lymphoid and non-lymphoid cells. Synthesis 
of K-light and s-heavy Ig chains and functionally active antibodies was observed in the above-mentioned transfected cell lines. 
Antibody engineering; Gene tandem expression; Phage T7 promoter; SpUO cell; CHO cell 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Many variants of recombinant antibodies, including 
the ‘humanized’ chimeric [l-3], reshaped [4-6], single- 
chain [7,8], bifunctional [2,9], and others, have been 
created during the past ten years (for review see [3,10]). 
Antibodies are known to be synthesized only by lym- 
phoid B cells. On the one hand, this is due to the struc- 
ture of promoters and enhancers which regulate the 
expression of immunoglobulin (Ig) genes [11,121, and on 
the other to specific transcription factors preferentially 
synthesized in B cells [13-l 51. The recombinant Ig genes 
may be expressed in lymphoid plasmacytoma cells and 
in alien systems [16,171. Earlier [ 18-201 a high level of 
the marker gene, chloramphenicol acetyltransferase 
(CAT), expression was shown in eukaryotic cells under 
the control of the ‘nuclear’ T7 RNA polymerase. We 
were interested in the possibility of expressing the Ig 
gene tandem in conditions similar to those described in 
[18]. In the present work a complete tandem of immu- 
noglobulin genes was created consisting of variable (V) 
genes of light (L) and heavy (H) chains obtained from 
the mouse hybridoma, and of genes of human constant 
(C) chains. The whole tandem was put under the control 
of the T7 RNA polymerase promoter. The eukaryotic 
cells steadily producing this polymerase were used as 
targets. Thus, conditions were created that allowed us 
to investigate the expression of the obtained construc- 
tion in both lymphoid and non-lymphoid cells. 
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2.1. Immunoglobulin ge es 
Clones containing the variable gene segments were obtained from 
the hybridoma PTF-02 genome (obtained courtesy of Dr. F. Franek, 
Institute of Molecular Genetics, Prague). Both V genes had been 
cloned and sequenced by us earlier [21,22]. Clones containing C genes 
of light (h--type) and heavy @-type) chains were obtained from the 
human genome [23]. 
Human C E- and K-genes, labelled with ‘*P, were used as DNA 
probes. 
2.2. Cell lines 
The myeloma cell line, Sp2/0, and the non-lymphoid CHO cells 
(Chinese hamster ovary) were used for transfection. Both cell lines 
contain in their genome a semisynthetic gene of T7 RNA polymerase 
[18] and steadily express this enzyme. An earlier modification of the 
polymerase [18] consisted of replacing the enzyme’s N-terminal part 
with a synthetic oligonucleotide sequence coding for amino acids 124 
133 of SW40 viral large T antigen. 
2.3. Cell transfection 
Co-transfection by plasmid pSV2-neo was carried out simultane- 
ously during the calcium phosphate transfection with plasmid 
PIG&k, and clone selection was done on selective medium containing 
geneticin G-418 (400 &ml for selection of the CHO cells and 1.5 
mg/ml for the Sp2/0 cell line. 
2.4. Radioimmune analysis 
Rabbit anti-human IgE and anti-s-chain antibodies, goat antibodies 
against rabbit antibodies, and protein A labelled with ‘*‘I, were used 
throughout he work. The antigen (pig transferrin) was obtained cour- 
tesy of Dr. F. Franek. To create the gene tandem and insert it into 
plasmids, recombinant DNA methods were applied. 
2.5. Enzymes and reagents 
Restriction endonucleases and other enzymes were obtained from 
the Institute of Applied Enzymology (Vilnius, Lithuania), agarose 
from Bio-Rad (USA), and other reagents from Sigma (USA). 
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3. RESULTS AND DISCUSSION 
The mouse Vn gene and human Cn gene were inserted 
into the pGEM1 plasmid under the control of T7 RNA 
polymerase promoter (Fig. 1). Sticky ends of an Hind111 
fragment of the V, gene and a BamHI fragment of the 
Cn gene were blunt-ended and intermediates formed by 
ligating their blunt ends. 
The mouse V, gene and human C, gene were first 
inserted into the pUC19 vector (Fig. 1). The Hind111 site 
within the recombinant gene was removed by blunt- 
ending using Klenow fragments of DNA polymerase, 
and the blunt ends of the V, and C, fragments were 
ligated. A linker containing the Hind111 site was at- 
tached to both ends of the recombinant V,C, gene. The 
final procedure consisted of binding the V,C, gene to 
the 3’ end of the VnC, gene. 
The lymphoid (Sp2/0) and non-lymphoid (CHO) cells 
which steadily produced the modified T7 RNA polym- 
erase (see section 2), were transfected with plasmid 
pIG.6ek, shown in Fig. 1, and geneticin-resistant clones 
were selected and analyzed. Northern analysis of 
mRNA synthesized in the transfected cells (not shown) 
revealed only an extended chain of mRNA (8.5-9.0 kb). 
This mRNA was able to hybridize with the “P-1abelled 
human C, and C, gene probes. No discrete RNA bands 
with the mobilities of individual mRNAs of L- and 
H-immunoglobulin chains were found in transfected 
cells (unlike the original hybridoma cell line). 
The cell lines which steadily synthesized these long 
mRNAs were used to reveal the expression of the L- and 
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Fig. 1. Construction of plasmid pIG6ek containing the mouse/human 
immunoglobulin gene tandem under the control of the T7 RNA 
polymerase promoter (for details see text). 
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Fig. 2. Western blot analysis of heavy (.s) and light (K) immunoglobulin 
chains synthesized by lymphoid (SpUO) and non-lymphoid (CHO) cell 
lines transfected with plasmid pIG.6ek. Lane C, untransfected; T, 
transfected cell lines. Numbers to the right of the blots indicate ap- 
proximate molecular weights in kDa. 
H-immunoglobulin chains. These polypeptide chains 
were identified by radioimmune analysis on electro- 
phoregrams of cellular extracts (rabbit antibodies and 
1251-labelled protein A). The transfected clones of Sp2/0 
and CHO cells synthesized both H (E-type) and light 
(x-type) immunoglobulin chains (Fig. 2). The molecular 
weights of 70 kDa and 25 kDa, respectively, for the 
heavy (E-type) and light (K-type) chains coincide in both 
cell lines; the heavy chain of the original hybridoma, 
PTF-02, has a much lower molecular weight (50 kDa), 
which was as expected since it belongs to the Gl class. 
The level of chimeric antibody production by the my- 
eloma cells, Sp2/0, exceeded that of the CHO cells. Indi- 
vidual clones synthesized up to 150 ng of chimeric anti- 
bodies in 1 ml. 
T7 RNA polymerase was shown earlier to be effective 
in gene transcription in eukaryotic cells [ 1 g-201. The T7 
transcripts are largely uncapped [191 and therefore their 
translation must proceed via a cap-independent mecha- 
nism. A scanning model has been proposed [24] to ex- 
plain the mechanism by which most eukaryotic mRNAs 
initiate translation. Nevertheless, the translation of un- 
capped poliovirus RNA is not satisfactorily accommo- 
dated within the scanning model [25]. In this case the 
initiation of translation occurs by ribosome binding to 
an internal sequence within the 5’ non-coding region of 
viral RNA [25]. Some eukaryotic mRNAs also contain 
putative internal ribosome entry sites in the 5’ untrans- 
lated region [26,27]. Which translation model is realized 
in our case: the scanning one or the internal initiation 
of both H- and L-chain reading frames? In this paper 
we present indirect evidence showing that the second 
mechanism is more likely (at least in non-lymphoid 
cells). Rather effective expression at the level of both 
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Fig. 3. Accumulation of chimeric antibodies in culture medium and 
cell extracts of CHO and SpUO cell lines transfected with plasmid 
pIG6ek. Open bars, cell extract; filled bars, culture medium. 
transcription and translation makes the system de- 
scribed here interesting for further analysis. 
The functional activity of chimeric antibodies was 
detected by their binding to antigen (pig transferrin). 
The antigen was immobilized on nitrocellulose filters 
and the antigen-bound antibodies isolated from the cell 
extracts were identified by radioimmune analysis. It was 
found that the transfected cells of both types (Sp2/0 and 
CHO) synthesized functional antibodies of the IgE 
isotype. In addition, the chimeric antibodies were iden- 
tified by radioimmune analysis according to their inter- 
action with the rabbit antibodies against human IgE. 
The effectiveness of chimeric IgE antibody secretion by 
the transfected cells was also studied. Fig. 3 shows that 
only Sp2/0 cells are capable of effective antibody secre- 
tion. It follows from the obtained results that non-lym- 
phoid CHO cells synthesize functionally active chimeric 
IgE antibodies but, unlike the lymphoid cells, they are 
not capable of active secretion of these antibodies. This 
fact can explain the decreased production of antibodies 
by the CHO cells compared to the Sp2/0 cells. 
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